×
About 178 results

ALLMedicine™ Acneiform Eruptions Center

Research & Reviews  50 results

Acne Fulminans
https://emedicine.medscape.com/article/1072815-overview

Jun 15th, 2022 - Practice Essentials Acne fulminans (AF), also known as acne maligna, was originally described as acute febrile ulcerative acne conglobata (AC). In 1958, at a meeting of the Detroit Dermatological Society, Burns and Colville presented a 16-year-old...

Acne Fulminans
https://emedicine.medscape.com/article/1072815-print

Jun 15th, 2022 - Practice Essentials Acne fulminans (AF), also known as acne maligna, was originally described as acute febrile ulcerative acne conglobata (AC). In 1958, at a meeting of the Detroit Dermatological Society, Burns and Colville presented a 16-year-old...

Acne Fulminans
http://emedicine.medscape.com/article/1072815-overview

Jun 15th, 2022 - Practice Essentials Acne fulminans (AF), also known as acne maligna, was originally described as acute febrile ulcerative acne conglobata (AC). In 1958, at a meeting of the Detroit Dermatological Society, Burns and Colville presented a 16-year-old...

Acne Fulminans
https://emedicine.medscape.com/article/1072815-

Jun 15th, 2022 - Practice Essentials Acne fulminans (AF), also known as acne maligna, was originally described as acute febrile ulcerative acne conglobata (AC). In 1958, at a meeting of the Detroit Dermatological Society, Burns and Colville presented a 16-year-old...

see more →

Drugs  4 results see all →

Clinicaltrials.gov  2 results

Timolol for the Treatment of Acne and Rosacea
https://clinicaltrials.gov/ct2/show/NCT02774590

Nov 11th, 2021 - Rosacea affects roughly 16 million Americans who desire better treatments than those currently available. Acne vulgaris, another chronic inflammatory skin disorder, mainly affects teenagers but also affects 20-40% of adults. Investigating potentia...

Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI
https://clinicaltrials.gov/ct2/show/NCT04864717

Sep 8th, 2021 - Background and Study Aims: Tyrosine Kinase inhibitors (TKIs) have become standard of care in patients with EGFR mutations in non-small cell lung cancer and other EGFR-mutated cancers. However, TKIs are well-known to cause cutaneous adverse events,...

see more →

News  15 results

Acneiform Eruptions More Severe With Targeted Therapy Combos
https://www.medscape.com/viewarticle/975030

Jun 3rd, 2022 - The study covered in this summary was published on researchsquare.com as a preprint and has not yet been peer reviewed. Key Takeaway Acneiform eruptions in patients with colorectal cancer are more extensive and severe when targeted cancer therapie...

Strategies to Minimize mTOR-Related Dermatologic Adverse Events
https://www.onclive.com/view/strategies-to-minimize-mtor-related-dermatologic-adverse-events

Dec 5th, 2020 - Mario E. Lacouture, MD Many patients being treated with mTOR inhibitors experience dermatologic-related adverse events. Dermatologic side effects can have a psychosocial effect on patients, by affecting areas of the body exposed to other peop...

Skin Reactions Common in Children on MEKI/BRAFI, Preventive Care Urged
https://www.medscape.com/viewarticle/934675

Jul 30th, 2020 - NEW YORK (Reuters Health) - Skin reactions are common in youngsters on MEKI/BRAFI therapy, often resulting in alterations or interruptions in cancer therapy, according to a multicenter retrospective study. "Every child in our study developed at le...

Subungual Hemorrhage From an Epidermal Growth Factor Receptor Inhibitor
https://www.mdedge.com/dermatology/article/216161/hair-nails/subungual-hemorrhage-epidermal-growth-factor-receptor
Josh A. Hammel, MD, Dean Elhag, MD et. al.

Jan 27th, 2020 - To the Editor: The epidermal growth factor receptor (EGFR) signaling pathway plays a role in the differentiation, proliferation, and survival of several cell types. 1 Erlotinib is an EGFR inhibitor that targets aberrant cells that overexpress this.

Cancer Drug Helpful for Children With Olmsted Syndrome
https://www.medpagetoday.com/dermatology/generaldermatology/84180

Jan 2nd, 2020 - A repurposed cancer drug shows promise for the treatment of a rare but disabling non-malignant disease in children that is characterized by palmoplantar keratoderma (PPK) and periorificial hyperkeratotic plaques, two case series indicated. In the ...

see more →